Sun Pharmaceutical receives approval for generic Casodex tablets

News Flash

IMPOSES 20% SAFEGUARD DUTY ON IMPORT OF SODA ASH
ROAD DEFICIT REMAINS THE GREATEST PROBLEM IN INFRASTRUCTURE IN INDIA
INDIA MAY TAKE TWO YEARS TO GET BACK TO 9% GROWTH
JET AIRWAYS RAISES FUEL SURCHARGE BY RS.200 ON SECTORS MORE THAN 1000 KM
JET AIRWAYS RAISES FUEL SURCHARGE BY RS.200 ON SECTORS MORE THAN 1000 KM
DOW JONES UP 0.17%, NASDAQ UP 0.34%, S&P 500 UP 0.25%
AIM TO HAVE 2 LARGE MILLS WITH 100 MT CAPACITY; TO CLOSE SMALLER ONES
WORRIED ABOUT DELAY IN AUCTION OF 3G SPECTRUM
HOPES INDIA 3G AUCTION HAPPENS EARLY
BHARTI HAS NOT SCALED DOWN ITS RETAIL PLANS
IN TALKS TO BUY CONTROLLING STAKE IN SUNIL HITECH: NW
E&Y ADVISORS FOR THE SUNIL HITECH BUY: NW
INDIABULLS OPEN OFFER LIKELY TO SUNIL HITECH SHAREHOLDERS: NW
10 LARGEST STEEL MILLS TO ACCOUNT FOR 75% OF STEEL OUTPUT
TO MERGE STEEL MAKERS TO CREATE RIVALS FOR ARCELORMITTAL
INDIA VICTIM OF TERRORISM FROM ACROSS BORDERS FOR THE LAST 25 YEARS
EDUCATION, HEALTH CARE SECTOR NEED MORE REFORMS
FDI INFLOWS OVER $120 BN SINCE 2001-02
GROWTH ESTIMATED AT 6.5% THIS FISCAL, TO WIND DOWN FISCAL STIMULUS NEXT YR
INDIA'S ECONOMY NOW MORE OPEN TO TRADE AND INVESTMENT
ECONOMY TO GROW ESTIMATED 6.5% THIS FISCAL
INDIA TO WIND DOWN FISCAL STIMULUS NEXT YEAR
TO LAUNCH A 3 SCREEN MULTIPLEX IN KANPUR
OCT STEEL SALES UP 38% AT 4.62 LAKH TONNES VS 3.35 LAKH TONNES (YOY)
OCTOBER CRUDE STEEL PRODUCTION UP 22% AT 599,000 TONS (YOY)
OCTOBER SAW THE BEST EVER PRODUCTION IN MOST UNITS
SMS BOS < space > stock query at 56388
COPPER DOWN TO $6490/TON ON WEAK DEMAND AND US UNEMPLOYMENT DATA
CRUDE FALLS 2.6% TO $77.43 BBL
Email us at buyorsell@ndtv.com

Updated: 08/07/2009 | 12:00 AM IST

Manufacturing

Capital Market

Wednesday, July 08, 2009 (New Delhi)

Blog

Comments:

Read (0)

Post

Rate the story

Sun Pharmaceutical Industries has announced that USFDA has granted its subsidiary an approval for an Abbreviated New Drug Application (ANDA) for generic Casodex, bicalutamide tablets.

These bicalutamide tablets, USP 50 mg are therapeutically equivalent to Casodex tablets from AstraZeneca. Casodex tablets have annual sales of approximately US$ 314 million in the US.

Bicalutamide tablets are an androgen receptor inhibitor indicated for use in combination therapy with a luteinizing hormone-releasing hormone (LHRH) analog for the treatment of Stage D2 metastatic carcinoma of the prostate.

The company made this announcement during the trading hours today, 08 July 2009.